Top Stories
Asymptomatic older adults with elevated pTau217 levels had about a 78% risk of developing cognitive impairment within 10 years.
Segmed's library spans more than 2800 healthcare partner sites and 150 million imaging studies.
Chai Discovery has secured AI-powered drug discovery partnerships with Novartis, Pfizer and Eli Lilly.
With the help of the PrecivityAD2 blood test results, primary care physicians were 93% accurate in diagnosing Alzheimer’s disease.
Moneta said 71% to 94% of Medicare patients improved across four measures in a model designed to reach rural neurology deserts, with therapist-rated outcomes meeting or exceeding in-person benchmarks.
Conference News
AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term GrowthVisit booth #112 in the Sparkle Ballroom at Fontainebleau Miami Beach for a live ...
FirstWord spoke with Zulfiqar Haider, Global Medical Director of Neurology at GE Healthcare, about where the current care pathway is struggling, and how imaging, quantification software, and other digital tools could help health systems scale screening and standardise monitoring in routine practice.
New research presented at the world's largest Alzheimer's conference shows digital cognitive testing catching dementia earlier in the clinic — and tracking brain health in firefighters exposed to year...
Beginning July 1, 2026, Anthem Blue Cross and Blue Shield medical policies support eligible blood-based biomarker testingNew peer-reviewed and AAIC data reinforce the clinical value of Quanterix's Luc...
ANAHEIM, Calif., July 14, 2026 /PRNewswire/ -- bioMérieux, a global leader in in vitro diagnostics, today announced it will showcase its latest diagnostic solutions and innovations at the 2026 Associa...



